EnRich Financial Partners’s ResMed RMD Stock Holding History

EnRich Financial Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-151	Closed	-$28.9K	–	246
2024 Q2	$28.9K	Buy	+151	New	+$30.6K	0.01%	123

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

EnRich Financial Partners's RMD Position: Q3 2024 in Review

EnRich Financial Partners sold out of ResMed (RMD) in Q3 2024, closing a stake of 151 shares — an estimated $28.9K sold.

EnRich Financial Partners first reported a position in RMD in Q2 2024 and held it in 1 quarter. The position peaked at $28.9K in Q2 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

EnRich Financial Partners reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
EnRich Financial Partners sold 151 ResMed shares in Q3 2024, an estimated $28.9K.
EnRich Financial Partners first reported a position in ResMed in Q2 2024 and held it in 1 quarter.
EnRich Financial Partners's ResMed position peaked at $28.9K in Q2 2024.
801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on EnRich Financial Partners's 13F filing for Q3 2024, filed 7 Nov 2024.